ZAI LAB LIMITED Increase (Decrease) in Deferred Income Taxes
ZAI LAB LIMITED (ZLAB) reported Increase (Decrease) in Deferred Income Taxes of $1.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2026-08-06
- ZAI LAB LIMITED increase (decrease) in deferred income taxes for fiscal 2025 was $3.34M.
- ZAI LAB LIMITED increase (decrease) in deferred income taxes for fiscal 2024 was $0.00.
- ZAI LAB LIMITED increase (decrease) in deferred income taxes for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|
| 2026-06-30 | $1.35M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $3.34M 10-K · filed 2026-02-26 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |